Results for: pharmaceutical+drug

Top Mylan shareholders seek deal with Teva - sources

Amgen tops estimates with 51 percent spike in 1Q profit

Teva's turnaround CEO sets sights on $40 billion mega-deal

Teva offers to buy Mylan in $40.1B cash-and-stock deal

Facebook revenue growth slows

Yahoo disappoints Wall Street

Generic drugmaker Teva makes $40 billion offer for rival Mylan

Teva offers $40 billion for Mylan

Wild horse advocates disagree on contraceptives for mustangs

Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake

Actavis, Warner Chilcott discussing combination

Cubist Pharma 1Q income falls after acquisition

Vertex rockets on positive cystic fibrosis results

BioCryst shares jump as flu concern grows in China

AcelRx Pharma rises as analyst starts at "Buy"

Tyco: No proof Lilly thieves used security report

Second camp for Syrian refugees opens in Jordan

Walgreen to acquire stake in AmerisourceBergen

AstraZeneca to cut 1,200 jobs in Delaware

Biolife seeks $5m for cancer drug trial

Movers roundup: Apple, Suntech

Hess, True Religion, Ferro are big movers

India rejects Bayer plea against cheap cancer drug

Acura Pharma jumps on Nexafed pharmacy deal

NJ drugmaker pleads to criminal charges

SciClone restating results, cites revenue errors

2 drug companies announce anemia drug recall

New PBS listings offer hope to hep C patients

Future science: Using 3D worlds to visualize data

Ahead of the Bell: Biogen shares keep climbing

Inovio Pharma slips on hepatitis C study data

Minister lauds cheap abortion pill moves

Nike, AK Steel, Tiffany are big movers

Court: Can drug companies pay to delay generics?

High court struggles over generic drug delay deals

BioMarin will continue Pompe disease drug studies

Drugmakers, Interpol ramp up fight against fakes

Pfizer painkiller gets longer patent protection

New WVU center will do human trials for new drugs

Pacira keeps rising analyst sees more gains ahead

Correction: HP Shareholder Revolt story

Medicines Co, Alnylam Pharma enter alliance

Ark. judge affirms $181 million in legal fees

Health care among early leaders in the S&P 500

FDA accepts application for new Sanofi MS drug

Onyx prices offering of up to 5 million shares

Correction: Pfizer-Antidepressant Suit story

News Summary: Surge of rare disease drugs in tests

Drug combo may fight pancreatic cancer

Monster shares fall under mounting pressure

Costly blood cancer drug gets PBS listing

WADA to introduce new 'steroid passport'

Rhoen-Klinikum to sell hospitals to Fresenius for $4 billion

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Rattled by investigations, foreign firms in China beef up compliance